The Massachusetts legislature is preparing its $1 billion life science bill that is supposed to reignite the state's biotech sector, but the bill is now laden with earmarks, reports the Boston Globe. Those include $49.5 million for a science center at the Massachusetts College of Liberal Arts, a school without a science graduate program; $12.6 million for a highway; and $12.9 million for a sewage treatment plant.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.